Skip to content
Clinical Trials – home

Laryngeal cancer Diagnostics

1 / 1 trials open to patients1 country

In short

Diagnosing laryngeal cancer early can make a significant difference in treatment outcomes and quality of life. Understanding when to seek testing, what diagnostic methods doctors use, and which tests may be needed for clinical trial enrollment helps patients navigate their journey with greater confidence and clarity.

Key points

  • Voice changes lasting more than two weeks should always be evaluated by a healthcare provider, especially if you have risk factors like smoking or heavy alcohol use.
  • Laryngeal cancer diagnosis requires multiple tests including physical examination, imaging scans, and most importantly, a biopsy to confirm the presence and type of cancer.
  • The location of cancer within the three sections of the larynx—supraglottis, glottis, or subglottis—significantly affects symptoms, diagnosis timing, and treatment approach.
  • Early detection dramatically improves outcomes, with early-stage laryngeal cancer being highly curable, often with treatments that preserve the voice box.
  • Clinical trial enrollment requires extensive diagnostic testing including staging assessments, imaging studies, organ function tests, and sometimes genetic testing of cancer cells.
  • Men are five times more likely than women to develop laryngeal cancer, with most cases occurring in people age 55 and older.
  • About one in four people who have had head and neck cancer previously may develop it again, making ongoing surveillance and early symptom reporting crucial.
  • Imaging technologies like CT scans and MRI provide detailed pictures that help determine tumor size, location, and whether cancer has spread to nearby structures or distant organs.

Introduction: Who Should Seek Diagnostic Testing

If you notice changes in your voice that last more than two weeks, it's time to talk to a healthcare provider. Many people mistake early signs of laryngeal cancer for a simple cold or seasonal illness, especially when the main symptom is hoarseness. However, persistent voice changes, a sore throat that won't go away, or difficulty swallowing are warning signals that deserve medical attention.

People who use tobacco products or drink alcohol heavily should be especially vigilant about these symptoms. The combination of smoking and drinking significantly increases the risk of developing cancer in the voice box. Those over age 55, men in particular, and anyone with a history of head and neck cancer should also monitor for symptoms carefully. About one in four people who have had head and neck cancer may develop it again, making regular check-ups important.

Certain occupations also put people at higher risk. If you work with substances like sulfuric acid mist, wood dust, nickel, asbestos, or in manufacturing environments with chemical exposures, you should be aware of throat symptoms. People who work with machines may also face increased risk.

Some forms of HPV (human papillomavirus), a sexually transmitted infection, can cause laryngeal cancer. This means younger people without traditional risk factors like smoking may also be at risk and should not ignore persistent throat symptoms.

Classic Diagnostic Methods

When you visit a healthcare provider with concerns about laryngeal cancer, the diagnostic process typically begins with a thorough conversation about your symptoms and medical history. The doctor will ask about voice changes, throat pain, swallowing difficulties, and any risk factors you may have. This is followed by a physical examination where the provider carefully examines your throat and neck, feeling for any lumps or swollen areas.

Physical Examination of the Throat and Neck

During the physical exam, your doctor will check the throat and neck for abnormal areas. Using a gloved finger, they will feel the inside of your mouth and examine your mouth and throat with a small, long-handled mirror and light. This examination includes checking the insides of your cheeks and lips, your gums, and the back, roof, and floor of your mouth. The doctor will also examine the top, bottom, and sides of your tongue and your throat. Your neck will be carefully felt for any swollen lymph nodes, which are small glands that can become enlarged when cancer spreads.

These initial examinations help determine whether further testing is necessary. If the doctor finds anything concerning during this initial assessment, you will likely need additional tests to confirm whether cancer is present.

Imaging Scans

Imaging tests create detailed pictures of the inside of your body, helping doctors see areas that cannot be examined during a physical exam. CT scans (computed tomography scans) and MRI scans (magnetic resonance imaging) are commonly used to diagnose laryngeal cancer. These scans provide detailed images that help doctors determine the size and location of tumors, and whether the cancer has spread to nearby tissues or lymph nodes.

A CT scan uses x-rays taken from different angles to create cross-sectional images of your body. An MRI scan uses powerful magnets and radio waves instead of x-rays to create detailed pictures of soft tissues. Both types of scans are painless, though you may need to receive a contrast material (a dye) through an injection to help certain areas show up more clearly in the images.

Laryngoscopy and Biopsy

One of the most important diagnostic procedures for laryngeal cancer is called laryngoscopy. This involves using a special instrument to look directly at your larynx. During the procedure, a thin tube with a light and lens at the end is passed through your nose or mouth to examine your voice box closely. This allows the doctor to see any abnormal areas or growths.

If something suspicious is found, the next step is usually a biopsy. A biopsy means taking a small sample of tissue from the abnormal area so it can be examined under a microscope in a laboratory. This is the only way to definitively diagnose cancer and determine what type it is. Most laryngeal cancers are squamous cell carcinoma, which means they form in the thin, flat cells lining the inside of the larynx.

The biopsy can be performed during a procedure called direct laryngoscopy, where you are given anesthesia so you won't feel any pain. The doctor uses specialized instruments to remove a tissue sample from the suspicious area. The tissue is then sent to a pathologist, a doctor who specializes in examining cells and tissues to diagnose diseases.

Fine-Needle Aspiration

If there are swollen lymph nodes in your neck, your doctor may perform a fine-needle aspiration. This procedure uses a thin needle to remove a small amount of fluid or tissue from a lymph node. The sample is then examined under a microscope to check for cancer cells. This test helps determine if the cancer has spread to the lymph nodes, which is important information for planning treatment.

Additional Diagnostic Tests

Depending on what initial tests show, you may need additional imaging studies. A PET scan (positron emission tomography scan) may be used in some cases to see if cancer has spread to other parts of the body. This test uses a small amount of radioactive sugar that is injected into your vein. Cancer cells absorb more of this sugar than normal cells, so they show up brighter on the scan images.

An endoscopy of the upper digestive tract may also be performed. This involves passing a flexible tube with a camera through your mouth to examine your esophagus and stomach. Because people with laryngeal cancer are at higher risk for cancers in other parts of the throat and digestive system, doctors may check these areas as well.

Diagnostics for Clinical Trial Qualification

If you are considering participating in a clinical trial for laryngeal cancer treatment, you will need to undergo specific diagnostic tests as part of the enrollment process. Clinical trials have strict criteria to ensure that participants are appropriate for the experimental treatment being studied and that the results will be scientifically valid.

Staging and Classification

Before enrolling in most clinical trials, your cancer must be carefully staged. Staging describes how much cancer is present in your body and where it has spread. The stage is determined based on the size of the tumor, whether it has grown into nearby tissues, whether it has spread to lymph nodes, and whether it has spread to distant parts of the body.

For laryngeal cancer, staging also depends on which part of the larynx is affected. The larynx has three main sections: the supraglottis (upper part above the vocal cords), the glottis (middle part where the vocal cords are located), and the subglottis (lower part between the vocal cords and windpipe). Each section has its own staging system because cancers in different locations behave differently.

Biopsy Confirmation

All clinical trials require confirmation through biopsy that you have laryngeal cancer. The biopsy sample is examined by a pathologist to confirm the diagnosis and determine the specific type of cancer cells present. This information helps researchers match patients to the most appropriate clinical trials. The pathologist will also assess the grade of the cancer, which describes how abnormal the cancer cells look under the microscope. Higher-grade cancers tend to grow and spread more quickly than lower-grade cancers.

Imaging Studies for Trial Enrollment

Clinical trials typically require recent imaging studies, including CT scans, MRI scans, or PET scans. These images serve as a baseline to measure how well the treatment works. During the trial, additional scans will be performed at specific intervals to compare changes in tumor size or spread. This allows researchers to objectively assess whether the experimental treatment is effective.

Assessment of Overall Health

Your general health status must also be evaluated before joining a clinical trial. This includes blood tests to check the function of your organs, particularly your kidneys, liver, and bone marrow. These tests help ensure that you are healthy enough to tolerate the experimental treatment and that the treatment won't cause severe complications.

Blood tests may include a complete blood count to check your red blood cells, white blood cells, and platelets. You may also need tests to measure your kidney function and liver enzymes. Some trials require testing for specific proteins or genetic markers in your cancer cells, as certain treatments only work for cancers with particular characteristics.

Assessment of Lymph Node Involvement

For many clinical trials, doctors need to know whether cancer has spread to lymph nodes in your neck. This is typically assessed through imaging studies and sometimes through fine-needle aspiration of any enlarged lymph nodes. The status of lymph nodes can determine which clinical trials you are eligible for, as some trials are designed specifically for early-stage disease while others focus on more advanced cancer.

Functional Assessments

Clinical trials may also require assessments of how the cancer affects your ability to speak, swallow, and breathe. These functional assessments serve as baseline measurements that can be compared after treatment. A speech-language pathologist may evaluate your voice quality and swallowing function. These assessments help researchers understand not just whether a treatment affects tumor size, but also whether it impacts your quality of life and daily functioning.

Eligibility Criteria

Each clinical trial has specific eligibility criteria that determine who can participate. These criteria are based on factors like the stage of your cancer, your age, your overall health, and what treatments you have already received. Some trials are only open to people who have not yet received any treatment, while others are specifically for people whose cancer has returned after initial treatment or has not responded to standard therapies.

The diagnostic tests required for clinical trial enrollment help ensure that participants meet these eligibility criteria. Your healthcare team will review the requirements of any clinical trials you are considering and explain which additional tests, if any, you need to complete before enrollment.

Prognosis and Survival Rate

Prognosis

The outlook for people with laryngeal cancer depends on several factors that affect how the disease progresses and responds to treatment. One of the most important factors is the stage of cancer at diagnosis. Early-stage laryngeal cancer, particularly cancer limited to the vocal cords that hasn't spread, is usually highly curable. The location of the cancer within the larynx also matters—cancers in the glottis, where the vocal cords are located, are often detected earlier because they cause noticeable voice changes right away.

Other factors that influence prognosis include your overall health and fitness level, whether you continue using tobacco or drinking alcohol after diagnosis, and how well the cancer responds to treatment. People who stop smoking and drinking after diagnosis generally have better outcomes than those who continue these habits. Your age and any other health conditions you have also play a role in determining your overall prognosis.

Whether the cancer has spread to lymph nodes or other parts of the body significantly affects the prognosis. Cancer that remains only in the larynx is generally easier to treat successfully than cancer that has spread. The grade of the cancer cells—how abnormal they look under a microscope—also matters, with higher-grade cancers typically being more aggressive.

Survival rate

Approximately 12,500 people in the United States are diagnosed with laryngeal cancer each year, and about 4,000 people die from it annually. This means that many people with laryngeal cancer can be successfully treated, especially when the disease is caught early.

Early-stage laryngeal cancer has a much better survival rate compared to advanced-stage disease. When cancer is detected before it has spread beyond the larynx, treatment with either surgery or radiation therapy alone often cures the disease. In these early cases, doctors can frequently preserve the larynx, allowing patients to maintain their natural speaking voice.

However, late-stage disease that has spread to nearby tissues, lymph nodes, or distant organs requires more intensive treatment and has a less favorable outlook. Advanced laryngeal cancer typically requires a combination of treatments, which may include surgery, radiation therapy, and chemotherapy. In some cases, more extensive surgery that removes all or most of the larynx may be necessary. Despite aggressive treatment, advanced-stage disease is associated with worse outcomes and may not be curable.

Did you know?

  1. The larynx is divided into three distinct sections—supraglottis, glottis, and subglottis—and each has its own separate staging system because cancers behave differently depending on their location.[2]
  2. More than half of laryngeal cancers (60%) start in the glottis where the vocal cords are, making voice changes often the first noticeable symptom that leads to early diagnosis.[1]
  3. Men are about five times more likely to develop laryngeal cancer than women, possibly because smoking and heavy alcohol consumption have historically been more common among men.[1]

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Laryngeal cancer

Recruiting trials first

See all 1 trials →
Quick filters

1 clinical trial in this condition

Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Universitaet Leipzig
See all 1 trials →filters applied: condition = Laryngeal cancer

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).